How do I write a prescription for Orthovisc (hyaluronic acid) 30 mg/2 mL prefilled syringe for a knee injection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

How to Prescribe Orthovisc for Knee Injection

Write the prescription as: "Orthovisc (hyaluronic acid) 30 mg/2 mL prefilled syringe, dispense 3-4 syringes, for intra-articular injection into the knee, administer one injection weekly for 3-4 consecutive weeks."

Prescription Details

The standard prescription format should include:

  • Drug name: Orthovisc (hyaluronic acid) 30 mg/2 mL prefilled syringe
  • Quantity: Dispense 3 or 4 syringes (depending on chosen regimen)
  • Directions: For intra-articular injection into knee joint
  • Dosing schedule: Administer one injection weekly for 3-4 consecutive weeks
  • Refills: None (patient returns for reassessment before any repeat course)

Dosing Regimen Options

Based on clinical trial evidence, you have two validated options 1:

  • 4-injection series: One 30 mg injection weekly for 4 consecutive weeks (most studied regimen)
  • 3-injection series: One 30 mg injection weekly for 3 consecutive weeks (also effective)

Both regimens show similar efficacy, so either is acceptable. The 4-injection series has slightly more supporting data.

Important Clinical Context

Evidence Considerations

The 2022 AAOS guidelines recommend AGAINST routine use of hyaluronic acid for knee osteoarthritis 2. Despite 17 high-quality and 11 moderate-quality studies, the evidence was inconsistent, with a number needed to treat of 17 patients. The guidelines note that while some patients benefit, current evidence cannot identify which subset of patients will respond favorably.

However, if you and your patient have decided to proceed with viscosupplementation after shared decision-making, the prescription format above is appropriate.

Patient Selection Pitfalls

Avoid prescribing Orthovisc for patients with:

  • Severe/advanced knee osteoarthritis (Kellgren-Lawrence grade 4) - poor response rates 3
  • Obesity - identified as a main factor for poor response 3
  • Contralateral knee pain >150 mm on WOMAC scale - associated with worse outcomes 4

Best candidates based on trial data:

  • Mild to moderate osteoarthritis (Kellgren-Lawrence grades 2-3) 1
  • WOMAC pain score 200-400 mm in index knee 1
  • Minimal contralateral knee pain (<150 mm) 4

Safety and Technique Requirements

Per EULAR guidelines, ensure 5:

  • Aseptic technique is mandatory for all intra-articular injections
  • Consider ultrasound guidance to improve injection accuracy
  • Patient should avoid overuse of injected joint for 24 hours post-injection, but immobilization is discouraged
  • Inform diabetic patients about potential transient hyperglycemia (though less relevant for HA than corticosteroids)

Practical Prescription Writing

The patient will pick up 3-4 prefilled syringes from the pharmacy. You (or your office) will then administer these injections over 3-4 consecutive weeks. The syringes are for office use, not for patient self-administration.

Storage note: Orthovisc should be stored at room temperature and protected from light until use.

References

5
Guideline

eular recommendations for intra-articular therapies.

Annals of the Rheumatic Diseases, 2021

Related Questions

What is the optimal dosage (concentration and amount) of compounded hyaluronic‑acid gel to improve skin quality?
For an adult with knee osteoarthritis and persistent pain despite acetaminophen, NSAIDs, physical therapy, and prior corticosteroid injections, is intra‑articular hyaluronic acid (viscosupplementation) indicated and what regimen is recommended?
Should I use a 1% or 5% topical hyaluronic acid gel for skin hydration?
Can hyaluronic‑acid lip filler be dissolved with hyaluronidase and re‑injected in the same session?
What is the evidence for intra‑articular hyaluronic acid injections in improving joint pain and function in knee osteoarthritis?
For a pregnant woman requiring antipsychotic treatment, what is a safe alternative to aripiprazole and what monitoring should be performed?
What is the maximum dose of Mucinex (guaifenesin) that can be taken at one time?
In a patient with a 20‑year history of ulcerative colitis, prior colectomy, currently off medication, presenting with pruritus, jaundice, mildly elevated transaminases (~100 U/L) and markedly elevated cholestatic enzymes, which diagnosis is most likely: primary sclerosing cholangitis, hepatitis C, pancreatic carcinoma, primary biliary cholangitis, or cholelithiasis?
What rapid‑acting prandial insulin and initial dosing should be used for a 120‑kg patient whose basal NPH insulin has been increased to approximately 36 U total?
What are the risk factors for esophageal adenocarcinoma, specifically chronic gastro‑oesophageal reflux disease, alcohol consumption, gastritis, and Barrett's esophagus?
For a 120‑kg patient with a total basal insulin dose of approximately 30 U, is it appropriate to increase the morning NPH insulin to 24 U and the bedtime NPH insulin to 12 U (about a 20 % increase)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.